Dubai Chapter
February 12th – 13th, 2025
Venue: Holiday Inn & Suites Dubai Science Park
Advancing Excellence in Pharmaceutical Vigilance, Regulatory Affairs and Quality Assurance.
Venue: Holiday Inn & Suites Dubai Science Park, an IHG Hotel, Dubai, UAE.
IHG Hotel, Dubai Science Park, Dubai, UAE.
At Drug Safety Symposium 2024, we are at the forefront of ensuring drug safety through the rigorous practices of pharmacovigilance, regulatory compliance, and quality assurance. Our premier gathering provides a dynamic platform where attendees can explore the latest industry trends, stay updated on regulatory changes, and discover innovative solutions that drive the pharmaceutical industry forward. We are committed to excellence and facilitating meaningful discussions, knowledge sharing, and collaboration.
Book NowIn an ever-evolving pharmaceutical landscape, the importance of drug safety cannot be overstated. Each day, countless lives depend on the efficacy and safety of pharmaceutical products. Our mission is to advance the critical mission of ensuring that every drug is not only effective but also safe for consumption.
Book NowWhat sets Drug Safety Symposium 2024 apart is our unique approach. We combine insightful knowledge sharing with interactive workshops and networking opportunities, all in an atmosphere of camaraderie and fun. It's not just an event; it's an experience that empowers you to make informed decisions and contribute to the highest standards of drug safety and quality.
Book NowWhat makes us unique?
- Global Thought Leadership
- Interactive Learning: We don't just talk; we engage
- Pre-Event Online Preparatory Meeting
- During the Event - Keynotes, Workshops, and More
- Post-Event Follow-Up Session
- MENA Regional Focus
- Cutting-Edge Technology
- Regulatory Insights
- Dubai as Your Host

Key Highlights
Pharmacovigilance Best Practices
Global Pharmacovigilance Trends and Strategies
Signal Detection and Management
Regulatory Compliance in Drug Safety
Navigating Complex Regulatory Frameworks
Good Pharmacovigilance Practices (GVP): An Overview
Regulatory Compliance and Reporting
FDA and EMA Regulations: A Comparative Analysis
Efficient Adverse Event Reporting
Emerging Trends in Drug Safety
Innovations in Pharmacovigilance: Harnessing Data and Technology
Artificial Intelligence and Machine Learning in Pharmacovigilance
Digital Health and Real-World Evidence
Cross Functional Collaboration
Clinical Trials and PV Intervention
Ensuring Data Integrity and Quality Assurance in PV Operations
Drug Labelling and Communication
Ensuring Patient Safety Through Quality Assurance
The Role of Quality Assurance in Drug Safety
Implementing Quality Control Measures for Drug Manufacturing
Navigating PV Audits: Best Practices, Do's, and Don'ts for Success
Innovations in Pharmacovigilance: Harnessing Data and Technology
Artificial Intelligence and Machine Learning in Pharmacovigilance
Digital Health and Real-World Evidence
Case Studies in Pharmacovigilance and Adverse Event Reporting
Clinical Trials and PV Intervention
Ensuring Data Integrity and Quality Assurance in PV Operations
Drug Labelling and Communication
Hands-On Signal Detection and Risk Management
The Role of Quality Assurance in Drug Safety
Implementing Quality Control Measures for Drug Manufacturing
Speakers
Executive Committee Member,ISoP and Founder of InnoVigilance (Canada)
International Safety Operations and Capabilities Lead
Ministry of
Health/registration
and Drug Control
Department
Patient Safety Cluster Lead - Middle East and Turkey, Takeda
Managing Director,
PVigilant Health
Head of Iraqi Pharmacovigilance Center- (MOH)
Associate Director - Non Drug Program, Novartis
Associate Director - Global Pharmacovigilance & Business Excellence,
Organon
A/Executive Director,
Marketed Health Products Directorate, Health Canada
Regional PV Consultant and PVQA Auditor, PQE Group
Director General Technical Assistant / Jordan Food & Drug Administration
Heads Global Pharmacovigilance & Clinical Operations, Arcolab
Regional Pharmacovigilance Hub Head (Middle East, Africa, India Subcontinent & Turkey)
Director General
The National Centre for pharmacovigilance -Algeria
Boehringer Ingelheim as a Head of Patients Safety and Pharmacovigilance of India Middle East Turkey and Africa region
Directeur Général, The Centre National for Pharmacovigilance, Tunisien
BPharm, M.Sc., MOAR
Director Medical Affairs ERTs & PKU, International Region
at BioMarin
Regulatory Affairs and Pharmacovigilance Director, Middle East, North and West Africa - Organon
PV Consultant,
United Kingdom
Patient Advocacy Lead and Founder, Ana Fareed
Associate Dean - Clinical Affairs & Professor at Dubai Pharmacy College for Girls, Dubai
Founder & CEO
PVCON Consulting & ISoP South Asia Chapter Lead
Past Speakers
Ministry of
Health/registration
and Drug Control
Department
and Africa, Boehringer Ingelheim*
Founder CEO, PVpharm (Madrid)
Managing Director,
PVigilant Health
Global Vigilance Manager
Julphar Pharma
QA Compliance, Jamjoom Pharma, Jeddah, KSA
Pharmaceutical Quality Control Quality Assurance, Aster Pharmacy
Director - Pharmacovigilance and Drug Information Department, Ministry of Health, Oman
Speakers
Ministry of
Health/registration
and Drug Control
Department
General Manager Advisor - Regulatory And Pricing Affairs, Jordan Food And Drug Administration
Managing Director,
PVigilant Health
Director - Pharmacovigilance and Drug Information Department, Ministry of Health, Oman
Pricing
Early Bird
(Till December 5th)
Standard
VIRTUAL
Early Bird
(Till December 5th)
USD 1000
Standard
USD 1200
In-person
Early Bird
(Till December 5th)
USD 1500
Standard
USD 1800
Standard
VIRTUAL
Standard
USD 1200
+5% VAT
In-person
Standard
USD 1800
+5% VAT
Dubai
What Can You Do In Dubai

22.2 KM Distance

12.7 KM Distance

22 KM Distance

19.3 KM Distance

15 KM Distance

18 KM Distance

26 KM Distance

103 KM Distance

2.6 KM Distance

15 KM Distance

15 KM Distance
